...
首页> 外文期刊>Annals of vascular surgery >Iatrogenic hepatic artery pseudoaneurysms: an uncommon complication after hepatic, biliary, and pancreatic procedures.
【24h】

Iatrogenic hepatic artery pseudoaneurysms: an uncommon complication after hepatic, biliary, and pancreatic procedures.

机译:医源性肝动脉假性动脉瘤:肝,胆,胰手术后的罕见并发症。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hepatic artery pseudoaneurysms are uncommon but potentially lethal complications of hepatic, biliary, and pancreatic interventions. To enhance our knowledge about these pseudoaneurysms, we reviewed our institution's experience with the management of these lesions. We reviewed the literature on 136 cases of hepatic artery pseudoaneurysms as well as our experience with 17 patients (excluding patients who were post-transplantation or had suffered abdominal trauma). The causes, pathogenesis, and clinical features were analyzed. Ten women and seven men developed hepatic artery pseudoaneurysms after undergoing hepatic (65%), biliary (30%), or pancreatic procedures (5%). The mean time between initial intervention and diagnosis was 5.7 months (range 7 days-38 months). Rupture occurred in 13 patients (76%). Mean pseudoaneurysm size was 1.9 cm (range 0.7-4 cm). Embolization was successful in 12 of 14 patients (86%). Four patients (24%), including the two who failed embolization, required operative intervention. Postoperative mortality was 25% while postembolization mortality was 14%. One patient was observed, and the aneurysm thrombosed at 72 months follow-up. Mean follow-up was 48 months (range 1-184 months) for 13 of the 14 survivors (93%) (1 patient was lost to follow-up) without any clinical sequela. Hepatic artery pseudoaneurysms are rare. Rupture is common and occurred in 76% of patients. For both ruptured and nonruptured cases angiography with embolization of the pseudoaneurysm is safe and effective. Operative intervention should be reserved for patients for whom embolization fails or for whom it is not feasible.
机译:肝动脉假性动脉瘤不常见,但可能会引起肝,胆和胰腺干预的致命并发症。为了增强我们对这些假性动脉瘤的认识,我们回顾了本机构在处理这些病变方面的经验。我们回顾了136例肝动脉假性动脉瘤的文献,以及我们对17例患者的经验(不包括移植后或遭受腹部创伤的患者)。分析了病因,发病机制和临床特征。 10名女性和7名男性在接受肝(65%),胆道(30%)或胰腺手术(5%)后出现了肝动脉假性动脉瘤。初次干预与确诊之间的平均时间为5.7个月(7天至38个月不等)。破裂发生在13名患者中(76%)。假性动脉瘤的平均大小为1.9厘米(范围0.7-4厘米)。 14例患者中有12例(86%)栓塞成功。 4例患者(占24%)需要手术干预,其中包括2例栓塞失败的患者。术后死亡率为25%,而栓塞后死亡率为14%。观察到一名患者,在72个月的随访中发现动脉瘤血栓形成。 14名幸存者中有13名(93%)(其中一名患者失去随访)的平均随访时间为48个月(1-184个月),无任何临床后遗症。肝动脉假性动脉瘤罕见。破裂很普遍,发生在76%的患者中。对于破裂和未破裂的病例,伴有假性动脉瘤栓塞的血管造影术是安全有效的。应为栓塞失败或不可行的患者保留手术干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号